101 related articles for article (PubMed ID: 4988538)
1. Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration.
Fagerhol MK; Abildgaard U
Scand J Haematol; 1970; 7(1):10-7. PubMed ID: 4988538
[No Abstract] [Full Text] [Related]
2. [Antithrombin and heparin-neutralizing activity in sera of women using and not using hormonal contraceptives].
Stepanauskas M; Weissbach-Rieger A; Schwarzenecker K; Hansche N; Egger E; Heine H
Z Med Lab Diagn; 1979; 20(5):295-301. PubMed ID: 549319
[No Abstract] [Full Text] [Related]
3. [Chromogenic and immunological determination of antithrombin III and of antiplasmin in subjects under treatment with oral hormonal contraceptives].
Savoldi R; Barezzani E
Quad Sclavo Diagn; 1979 Mar; 15(1):152-63. PubMed ID: 542593
[TBL] [Abstract][Full Text] [Related]
4. Implications of depressed antithrombin-3 activity associated with oral contraceptives.
Zuck TF; Bergin JJ; Raymond JM; Dwyre WR
Surg Gynecol Obstet; 1971 Oct; 133(4):609-12. PubMed ID: 5096309
[No Abstract] [Full Text] [Related]
5. [Antithrombin 3 concentration in the blood].
Fagerhol M; Abildgaard V
Nord Med; 1970 Nov; 84(46):1473. PubMed ID: 4098091
[No Abstract] [Full Text] [Related]
6. [Normal values of leukocytes, basophilic granulocytes and antithrombin activities in blood donors].
Frick G; Frick U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(1):87-97. PubMed ID: 4121134
[No Abstract] [Full Text] [Related]
7. [Letter: Pill and antithrombin. Effects of the pill on progressive antithrombin activity and plasmatic concentration of 3 antithrombins].
Marcel GA; Sabatier C; Casper C; Warniez C
Nouv Presse Med; 1973 Nov; 2(42):2820-1. PubMed ID: 4773655
[No Abstract] [Full Text] [Related]
8. [Studies on antithrombin by TAD method and immunological method].
Nagata H; Watanabe N; Hasegawa H
Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):192-6. PubMed ID: 407760
[No Abstract] [Full Text] [Related]
9. A preliminary report on the relationship between serum anti-thrombin III concentration in pre- and post-operative patients and in women on oral contraceptives.
Ton SH; Lopez CG; Thiruselvam A; Lyou YT
Med J Malaysia; 1981 Dec; 36(4):212-4. PubMed ID: 7334955
[No Abstract] [Full Text] [Related]
10. Plasma binding of pancuronium: effects of age, sex, and disease.
Wood M; Stone WJ; Wood AJ
Anesth Analg; 1983 Jan; 62(1):29-32. PubMed ID: 6849508
[TBL] [Abstract][Full Text] [Related]
11. [Oral contraceptives and antithrombin-3].
Naess K
Tidsskr Nor Laegeforen; 1971 Apr; 91(12):892. PubMed ID: 5554782
[No Abstract] [Full Text] [Related]
12. Biological antithrombin III levels.
Bick RL
JAMA; 1978 Jan; 239(4):296. PubMed ID: 579407
[No Abstract] [Full Text] [Related]
13. Antithrombin 3 and oestrogen content of oral contraceptives.
Howie PW; Prentice CR
Lancet; 1973 Jun; 1(7817):1455. PubMed ID: 4123033
[No Abstract] [Full Text] [Related]
14. Antithrombin-3 concentration and ABO blood-groups.
Fagerhol MK; Abildgaard U; Kornstad L
Lancet; 1971 Sep; 2(7725):664-5. PubMed ID: 4105980
[No Abstract] [Full Text] [Related]
15. Assay of progressive antithrombin in plasma.
Abildgaard U; Gravem K; Godal HC
Thromb Diath Haemorrh; 1970 Oct; 24(1):224-9. PubMed ID: 5483962
[No Abstract] [Full Text] [Related]
16. Oral contraceptives and anti-thrombin-3 activity: a new method of antithrombin estimation.
Howie PW; Prentice CR; McNicol GP
Clin Sci; 1972 Jul; 43(1):2P. PubMed ID: 5064809
[No Abstract] [Full Text] [Related]
17. [Can the measurement of antithrombin-3 point out women who run the risk of thrombosis with the use of P-pills?].
Fagerhol MK; Abildgaard U
Tidsskr Nor Laegeforen; 1970 Aug; 90(16):1559-60. PubMed ID: 5457809
[No Abstract] [Full Text] [Related]
18. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
Jørgensen M; Petersen LC; Thorsen S
J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
[TBL] [Abstract][Full Text] [Related]
19. Bothrops jararaca antithrombin: isolation, characterization and comparison with other animal antithrombins.
de Morais KB; Vieira CO; Hirata IY; Tanaka-Azevedo AM
Comp Biochem Physiol B Biochem Mol Biol; 2009 Feb; 152(2):171-6. PubMed ID: 19049827
[TBL] [Abstract][Full Text] [Related]
20. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
